EMEA-001308-PIP01-12-M02

Key facts

Invented name
Abraxane
Active substance
paclitaxel
Therapeutic area
Oncology
Decision number
P/0257/2018
PIP number
EMEA-001308-PIP01-12-M02
Pharmaceutical form(s)
Powder for suspension for injection
Condition(s) / indication(s)
Treatment of solid malignant tumours
Route(s) of administration
Intravenous use
Contact for public enquiries
Celgene Europe Limited

Tel.  +41 327298500
E-mail: medinfo.intl@celgene.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001308-PIP01-12-M02
Compliance opinion date
21/09/2018
Compliance outcome
positive

Decision

How useful was this page?

Add your rating